Format

Send to

Choose Destination
Adv Pharm Bull. 2014 Dec;4(Suppl 2):555-61. doi: 10.5681/apb.2014.082. Epub 2014 Dec 31.

The Effect of Omega-3 Fatty Acids on ARDS: A Randomized Double-Blind Study.

Author information

1
Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
2
Applied Drug Research Center, Department of Clinical Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
3
Tuberculosis & Lung Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
4
Road Traffic Injury Research Center, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, Iran.
5
Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Abstract

PURPOSE:

The aim of this study was to evaluate the effect of an enteral nutrition diet, enriched with omega-3 fatty acids because of its anti-inflammatory effects on treatment of patients with mild to moderate ARDS.

METHODS:

This randomized clinical trial was performed in two ICUs of Tabriz University of Medical Sciences from Jun 2011 until Sep 2013 in north west of Iran. Fifty-eight patients with mild to moderate ARDS were enroled in this clinical trial. All patients received standard treatment for ARDS based on ARDS network trial. In intervention group, patients received 6 soft-gels of omega-3/day in addition to the standard treatment.

RESULTS:

Tidal volume, PEEP, pH, PaO2/FiO2 , SaO2, P platue and PaCO2 on the 7(th) and 14(th) days didn't have significant difference between two groups. Indices of lung mechanics (Resistance, Compliance) had significant difference between the groups on the 14(th) day. Pao2 had significant difference between two groups on both 7(th) and 14(th) days. Trend of PaO2 changes during the study period in two groups were significant. We showed that adjusted mortality rate did not have significant difference between two groups.

CONCLUSION:

It seems that adding omega-3 fatty acids to enteral diet of patients with ARDS has positive results in term of ventilator free days, oxygenation, lung mechanic indices; however, we need more multi center trials with large sample size and different doses of omega-3 fatty acids for their routine usage as an adjuant for ARDS treatment.

KEYWORDS:

ARDS; ICU; Inflammation; Omega-3 fatty acids

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center